The National Cancer Institute (NCI) awarded a $872,878 Project Grant under the Cancer Cause and Prevention Research program (CFDA 93.393) to the University of California, Davis (UC Davis) to conduct the Latin America Genomics of Breast Cancer Risk Study (LAGENO-BCR). The primary objectives are to: 1) Discover new genetic variants and genes associated with breast cancer risk in Hispanic/Latina populations, including by cancer subtype, through genome-wide association studies and transcriptome-wide association analyses; and 2) Develop improved breast cancer risk prediction models that account for ancestry and geographic diversity.
As a sub-award under this grant, the Centro Comprensivo De Cancer De La Universidad De Puerto Rico will provide data from their Puerto Rico Breast Cancer Genetics and Genomics Study, participate in the analyses, and coordinate efforts with other Latin American collaborators. The sub-award is valued at $240,810 and runs from January 2025 to the project's end date of August 2029.
Generated 3/18/25, 1:44 AM